XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 Latest Research
  Risk Factors
  Rectal Cancer
  Pancreatic Cancer
  Bone Cancer
  Cervical Cancer
  Testicular Cancer
  Gastric Cancer
  Ovarian Cancer
  Nerve Tissue
  Renal Cell Carcinoma
 Infectious Diseases
 Respiratory Medicine
 Public Health
 Clinical Trials
 Medical News
 Awards & Prizes
 Special Topics
 Odd Medical News
 World News

Last Updated: Nov 17th, 2006 - 22:35:04

Vaccination Channel
subscribe to Vaccination newsletter

Latest Research : Cancer : Therapy : Vaccination

   DISCUSS   |   EMAIL   |   PRINT
Use of iNKT cells boosts tumor vaccination strategy
Dec 16, 2004, 17:51, Reviewed by: Dr.

T cell responses to natural infection are orders of magnitude greater than those observed in cancer patients in response to current vaccination protocols. Optimizing tumor vaccination protocols will require a deeper understanding of the signals that the immune system coordinates in order to respond to pathogenic infection. In the December 15 issue of the Journal of Clinical Investigation, Vincenzo Cerundolo and colleagues from the University of Oxford report a vaccination approach in mice in which intravenous delivery of a protein antigen plus a type of NK T cells, known as iNKT cells, enhanced the immune response and cleared an established tumor.

The authors demonstrate that the approach is effective when the vaccine is delivered orally or intravenously and could be exploited in future vaccination protocols aimed at eliciting immune responses against cancer and infectious diseases.


- December 15 issue of the Journal of Clinical Investigation

TITLE: Utilizing the adjuvant properties of Cd1d-dependent NK T cells in T cell–mediated immunotherapy

Subscribe to Vaccination Newsletter
E-mail Address:


Related Vaccination News

First ever shots of the cervical cancer vaccine administered in Queensland
Scientists one step closer to cancer vaccine
Response to Cancer Vaccine Enhanced by Chemotherapy
Ligand Treatment of Treg Cells Enhanced Anti-Tumor Immunity
Prostate Cancer Vaccine gets Special Protocol Assessment by FDA
A Vaccine For Carcinoma Cervix
Use of iNKT cells boosts tumor vaccination strategy
First integrated immune cell response promises hope in cancer vaccine research

For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page


© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us